XML 47 R39.htm IDEA: XBRL DOCUMENT v3.23.3
Summary of Significant Accounting Policies - In-Licensing Arrangements - Development (Details) - Option and license agreement - Zymeworks Inc
$ in Millions
1 Months Ended
Apr. 30, 2022
USD ($)
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
Commercial option to extend research license 2 years
Upfront consideration for purchase of license $ 5.0
Term of the research license 2 years
Research and development  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
Upfront consideration for purchase of license $ 5.0